bioRxiv Science⌕ Search

Biology subjects

Wess, G.

Publications and source records attributed to Wess, G..

2 recordsLinked to original sources

A scalable, clinically severe pig model for Duchenne muscular dystrophy

Large animal models for Duchenne muscular dystrophy (DMD) are crucial for preclinical evaluation of novel diagnostic procedures and treatment strategies. Pigs cloned from male cells lacking DMD exon 52 (DMD{Delta}52) resemble molecular, clinical and pathological hallmarks of DMD, but cannot be propagated by breeding due to death before sexual maturity. Therefore, female DMD+/- carriers were generated. A single founder animal had 11 litters with 29 DMDY/-, 34 DMD+/- as well as 36 male and 29 female wild-type (WT) offspring. Breeding with F1 and F2 DMD+/- carriers resulted in additional 114 DMDY/- piglets. The majority of them survived for 3-4 months, providing large cohorts for experimental studies. Pathological investigations and proteome studies of skeletal muscles and myocardium confirmed the resemblance of human disease mechanisms. Importantly, DMDY/- pigs reveal progressive fibrosis of myocardium and increased expression of connexin-43, associated with significantly reduced left ventricular fractional shortening and ejection fraction already at age 3 months. Furthermore, behavioral tests provided evidence for impaired cognitive ability of DMDY/- pigs. Our breeding cohort of DMD{Delta}52 pigs and standardized tissue repositories from DMDY/- pigs, DMD+/- carriers, and WT littermate controls provide important resources for studying DMD disease mechanisms and for testing novel diagnostic procedures and treatment strategies.

pathology↗

Doberman pinschers present autoimmunity associated with functional autoantibodies: a model to study the autoimmune background of human dilated cardiomyopathy

BackgroundAutoimmunity associated with autoantibodies directed against the {beta}1-adrenergic receptor ({beta}1-AAB) is increasingly accepted as driving human dilated cardiomyopathy (DCM). Unfortunately, animal models of DCM are lacking, preventing our knowledge about {beta}1-AAB autoimmunity in DCM from being extended and hindering the development of related treatment strategies.\n\nObjectivesTo introduce an animal model, we studied Doberman pinschers, which develop cardiomyopathy (DoCM), with similarities to human DCM, with regard to their {beta}1-AAB autoimmunity.\n\nMethodsEighty-seven DP with DoCM and 31 (at enrolment) healthy controls were analyzed for {beta}1-AAB; the receptor binding site and sensitivity to inhibition were determined. In controls who developed cardiomyopathy during the follow-up, {beta}1-AAB were analyzed during the DoCM progress.\n\nResultsFifty-nine (67.8%) DoCM dogs and 19 (61.3%) controls were {beta}1-AAB positive. Excluding the 9 controls who developed DoCM in the follow-up, {beta}1-AAB positivity tended to be more pronounced in DoCM.\n\nFrom the controls who developed DoCM, 8 were {beta}1-AAB positive (p=0.044 vs. dogs remaining healthy); their {beta}1-AAB level increased with the cardiomyopathy progress. Overall mortality and mortality exclusively due to cardiac reasons during the study period, were higher (p=0.002; p=0037) in {beta}1-AAB positive dogs. The dogs {beta}1-AAB targeted a specific epitope centralized on the second extracellular receptor and were sensitive to inhibition by drugs already successful tested for the corresponding human autoantibody.\n\nConclusionsDoberman pinschers presented {beta}1-AAB associated autoimmunity similar to that driving the pathogenesis of human DCM. Consequently, DP could remove the lack of animal models available for studying {beta}1-AAB autoimmunity in DCM.

pathology↗